Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.
Arthritis & rheumatology (Hoboken, N.J.) · 2023 · 209 citations · Nikolay Delev
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis.
The New England journal of medicine · 2025 · 72 citations · Arathi Setty
Intra-articular Hyaluronic Acid Treatments for Knee Osteoarthritis: A Systematic Review of Product Properties.
Cartilage · 2023 · 49 citations · Damion Martins
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination.
Arthritis & rheumatology (Hoboken, N.J.) · 2022 · 123 citations · Allison Guttmann
Update on gout management: what is old and what is new.
Current opinion in rheumatology · 2022 · 66 citations · Yuliya Afinogenova
Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus.
The New England journal of medicine · 2022 · 79 citations · Nikolay Delev
Mixed reality applications in upper extremity surgery: the future is now.
EFORT open reviews · 2024 · 9 citations · John Erickson
The effect of humeral tray thickness on glenohumeral loads in a reverse shoulder 'smart' implant.
International orthopaedics · 2024 · 7 citations · John Erickson